GSK plc reports that various executives acquired shares on July 16, 2024, following dividend reinvestments from payments made on July 11, 2024, at a price of £14.9318 per share. The transactions included 1,880.862 shares, 740.397 shares, and others, totaling significant volumes across different executives and positions.